Immune checkpoint inhibitors <i>versus</i> chemotherapy as second-line therapy for advanced oesophageal squamous cell carcinoma: a systematic review and economic evaluation.

Authors:
Liu S; Dou L; Li S.

Journal:
Therap Adv Gastroenterol

Publication Year: 2024

DOI:
10.1177/17562848241233134

PMCID:
PMC10903196

PMID:
38425370

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: Therap Adv Gastroenterol

Detailed journal information not available.

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."

Evidence found in paper:

"Trial registration: This study has been registered on the PROSPERO database with the registration number CRD42023495204."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025